Podcasts about tidepools

Most medical care is backed by varying types of evidence, yet we apply higher standards to digital health tools before they're trusted, adopted, or reimbursed.In this special episode, guest host Lucia Savage is joined by Dr. Vindell Washington of Verily and Dr. Aaron Carroll of AcademyHealth for a candid conversation about the uneven standards we apply to digital versus traditional care. Together, they explore how we define evidence, whose voices shape that definition, and what it takes to build trust in an AI-powered healthcare future.We cover:

Hosts Ryan Callaghan, Randall Williams, and Corinne Schneider take the good news with the bad on the public lands front, get a tour of the goodies at Gulf of Maine Inc. from "Tidepool" Tim Sheehan, suss out fake news, catch up with Jordan Sillars about his "Blood Trails," and get served a MeatEater Menu. Watch the live stream on the MeatEater Podcast Network YouTube channel. Connect with The MeatEater Podcast Network MeatEater on Instagram, Facebook, Twitter, and YouTubeSee omnystudio.com/listener for privacy information.

Welcome to this special edition of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosted by Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center. Included as part of the HCPLive This Year in Medicine series, this episode recaps headlines and practice updates related to continuous glucose monitoring (CGM) from the past year, with a focus on regulatory news from Medtronic, Dexcom, Abbott, and Senseonics. In recognition of the 25th anniversary of the first US Food and Drug Administration (FDA) approval of a CGM device in 1999, hosts also provide historic context for each company spotlighted during the episode. Medtronic To begin the episode, hosts start where the journey began: the FDA approval of the MiniMed in June 1999. In the 25 years since, MiniMed was acquired by Medtronic but has continued to remain among the leaders in CGM technology. During their conversation, hosts spend time discussing early experiences with CGM as well as newer advances from Medtronic, including the 2024 approval of the Simplera CGM. Dexcom Conversation around Dexcom ranges from the company's STS sensor in 2006 to the current G7 model as well as integration with pumps like the OmniPod 5, T:slim X2, and the Islet. When discussing news from 2024 from Dexcom, hosts call attention to the partnership with the Oura Ring and the launch of Stelo, the first FDA-approved over-the-counter CGM. Abbott Next, hosts dive into advancements from Abbott—starting with the Navigator and advancing to the Libre, including the Libre 3 plus, which features real-time data and 15-day wear. The hosts also celebrate Abbott's collaborations with Tidepool and major insulin pump manufacturers as well as the FDA clearance of the Lingo and Libre Rio. Senseonics The episode concludes with a discussion of Senseonics' Eversense CGM, the only FDA-approved implantable CGM. As the hosts highlight, Eversense has progressed over the years from a 90-day sensor to the groundbreaking 365-day wear system, which received approval in 2024. The hosts also highlight the potential of future developments, such as eliminating the external transmitter for a fully implantable design. Key Timestamps 00:00 - Start 01:37 - 25 Years of CGM 02:20 - Medtronic CGM History & Updates 05:01 - Dexcom CGM History & Updates 10:06 - Abbott CGM History & Updates 15:48 - Eversense CGM History & Updates

This episode spotlights news in diabetes technology from the latter half of October 2024. In the episode, hosts breakdown updates from multiple companies related to continuous glucose monitoring and insulin delivery. A brief overview of announcements covered in the episode by hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, can be found below: Abbott's FreeStyle Libre 3: On October 30, 2024, Beta Bionics Inc announced the integration of the iLet Bionic Pancreas with Abbott's FreeStyle Libre 3 Plus sensor. According to hosts, the new compatibility broadens choice for patients and offering flexibility in CGM usage. Additionally, this sensor has also been approved for use during MRI and CT scans, eliminating the need to remove the device, which adds convenience for patients requiring frequent imaging. Integration with Tidepool: On October 28, 2024, Tidepool announced a new data integration with Abbott. With this integration, the Libre 3 now connects with Tidepool, allowing data from multiple CGMs to be consolidated in a single platform, streamlining data review for clinicians and patients and reducing training requirements. Omnipod 5 for iOS: on October 29, 2024, Insulet Corporation announced the full market release of its Omnipod 5 App for iPhones in the US. Now available for iPhone users (using Dexcom G6), the update allows features like preset meal settings, a valuable tool for patients who use flexible carb counting approaches. Relevant disclosures for Isaacs include Eli Lilly and Company, Novo Nordisk, Sanofi, Abbott Diabetes Care, Dexcom, Medtronic, and others. Relevant disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and others.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: iPhone control for Omnipod 5 rolls out, Libre is approved for use in CT scans and MRIs, Dexcom files for 15 day wear, Luna nighttime pump goes to trial, iLet cell trials move forward and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Insulet Corporation announces the full market release of the Omnipod 5 App for iPhone® in the U.S. App allows users to fully control their Omnipod 5 Automated Insulin Delivery System (Omnipod 5) from their compatible iPhone1. For example, users can bolus for a meal, change a Pod, and adjust settings. Importantly, this also means that Omnipod 5 users who have a compatible iPhone no longer need to carry a separate Controller to help manage their insulin delivery requirements. Insulet says that the App for iPhone has been the number one feature requested by Omnipod 5 users. The Omnipod 5 App for iPhone is currently compatible with the Dexcom G6 Continuous Glucose Monitoring (CGM) System and is expected to be compatible with the Dexcom G7 CGM in the U.S. in 2025. The Omnipod 5 App for Android phones is also available to U.S. customers. https://www.businesswire.com/news/home/20241029838744/en/Omnipod%C2%AE-5-App-for-iPhone%C2%AE-Now-Fully-Available-in-the-United-States   XX Th FDA says it's okay to keep on your FreeStyle Libre 2 and 3 for procedures like X-rays, CT scans and MRIs. Abbott said it makes its systems the first and only patient-applied CGM sensors approved for these screenings. Imaging procedures often come as part of diabetes care, Abbott said, especially as diabetes can cause a number of medical complications. The company rigorously tested its Libre 2 and 3 sensors to ensure they remain effective after radiologic procedures. This FDA clearance comes with no changes made to the sensor.   https://www.drugdeliverybusiness.com/fda-approves-abbott-cgms-medical-imaging/ XX Tidepool announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors (CGMs). The companies aim to deliver cloud-to-cloud integration for an automatic stream of data from patients using Abbott's CGMs in the U.S. Data streams to Tidepool+, a diabetes data visualization and population health platform. Tidepool+ provides intuitive tracking and visualization of diabetes data to make the data informative and actionable for clinicians, people with diabetes and caregivers. https://www.drugdeliverybusiness.com/tidepool-abbott-data-integration-freestyle-libre/ XX Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) FreeStyle Libre 3 Plus. The companies announced their plan to combine the FreeStyle Libre 3 Plus continuous glucose monitor (CGM) with iLet last month. According to Beta Bionics, this makes iLet the first available automated insulin delivery (AID) system to integrate with Libre 3 Plus in the U.S. iLet users can now update their app and software to gain a choice of integrated CGMs. They can choose between Libre 3 Plus and Dexcom CGMs.   Abbott, meanwhile, continues to push forward on the automated insulin delivery integration front. The company recently paired its FreeStyle Libre 2 Plus with Insulet's Omnipod 5 in Europe. It also announced compatibility with the Tandem Diabetes Care t:slim X2 system in January.   Notably, the company also struck a deal with Medtronic in August. They aim to develop CGMs specifically for the medtech giant's own insulin delivery systems. https://www.drugdeliverybusiness.com/beta-bionics-launches-ilet-abbott-libre/ XX Dexcom is asking the FDA to approve the G7 CGM for 15 days. Right now the G7 has a 10 day wear time.  Dexcom also launched the G7 CGM in Australia and rolled out Dexcom ONE+ in France. Some front-office news.. EVP and CCO Teri Lawver plans to retire at the end of the year. https://www.drugdeliverybusiness.com/dexcom-submits-15-day-cgm-fda-q3-2024/ XX Stelo by Dexcom is one of TIME's Best Inventions of 2024! As the first glucose biosensor available in the U.S. without a prescription, Stelo has unlocked our industry-leading technology for millions of people across the U.S. looking to improve their health through personalized insights. We're honored to be recognized among other unique innovations in the Home Health category that support people's health. https://time.com/7094684/dexcom-stelo/   XX   Luna Diabetes is moving forward with a pivotal trial evaluating its automated closed-loop insulin technology, the Luna System. This is designed to address nighttime glucose control for insulin pen users. It's meant for use only during sleep - Luna system was developed as a wearable insulin pump and alternative to insulin pen to automate the insulin delivery process. The device works with continuous glucose monitors (CGM) to calculate and deliver rapid-acting insulin doses during sleep. Luna Diabetes expects the study to be completed early next year, with plans to commercially launch the device “soon after”.   https://finance.yahoo.com/news/luna-diabetes-trials-automated-wearable-115211566.html?guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAJIrWwjdye-ehrLNDt-LIGb5qTXaKDTIa8NWwiT7fKwFFgjDMN2nnINis6YfFePWP2ZA2DVYWXEIZQqRlQ4aKLFrYWgvw1jdI-t1n9kO6NIzdBCMXQNNCVl_S-75lDNip2SysHDJQmyqSc4wLjfDya3v9wwTWU-KgE_OqrPCTnlu XX Researchers are urging  caution when prescribing off-label glucose-lowering drugs to individuals with type 1 diabetes (T1D) while acknowledging that doctors keep prescribing them because they seem to work so well. Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown significant benefits for cardiovascular and renal health in other populations, particularly in patients with type 2 diabetes.   SGLT2 inhibitors carry a significant risk of euglycemic diabetic ketoacidosis, a dangerous condition most common in T1D individuals where toxic levels of blood acidification can occur. Due to this risk, SGLT2 inhibitors were removed for T1D use in Europe, and the U.S. Food and Drug Administration (FDA) has not approved them for T1D.   For GLP-1RAs, there are concerns about substantial weight loss potentially leading to ketoacidosis or worsening hypoglycemia. While these medications can be beneficial in managing weight, the extent of that weight loss can create new problems in people with T1D as their insulin needs may quickly change as a result. Prescribing in People With Type 1 Diabetes," published in JAMA, the authors stress the critical need for more research to confidently allow the off-label usage of potentially dangerous secondary treatments. The data suggests clinicians are turning to these treatments to manage cardiovascular and renal complications in T1D patients, even though the drugs are not explicitly approved for this condition.   Conversely, those newly prescribed GLP-1RAs had higher rates of obesity (69.4% vs. 45.7%). This data indicates that clinicians are prescribing GLP-1RAs to help manage obesity in T1D patients, as weight management is a critical component of diabetes care.   The percentage of the T1D population prescribed GLP-1RAs increased significantly, from 0.3% in 2010 to 6.6% by 2023. The percentage prescribed SGLT2 inhibitors rose from 0.1% in 2013 to 2.4% by 2023. Overall, the percentage of T1D patients prescribed either of these medications increased from 0.7% to 8.3% during this period.     Results of the study suggest that despite regulatory concerns, off-label use of GLP-1RAs and SGLT2 inhibitors in T1D continues to grow primarily due to their cardiorenal and weight management benefits.   "Prospective studies on the efficacy and safety of GLP-1RAs or SGLT2 inhibitors in the T1D population are needed," the Research Letter concludes, "Before such evidence becomes available, caution should be exercised when prescribing these treatments to individuals with T1D."   https://medicalxpress.com/news/2024-10-glucose-lowering-drugs-diabetes-patients.html XX More good islet transplant news.. from Eledon Pharmaceuticals and University of Chicago. These are potentially the first human cases of insulin independence achieved using a transplant of insulin-producing islet cells in combination with its experimental immunosuppressant drug. The first two subjects achieved insulin independence and normal hemoglobin A1C (HbA1c) levels, a measure of average blood glucose, post-transplant. The third subject, who recently received an islet transplant, decreased insulin use by more than 60% three days following the procedure and continues on an insulin independence trajectory. Some of the funding for this study comes from Breakthrough T1D. https://www.globenewswire.com/news-release/2024/10/29/2970713/0/en/Eledon-Pharmaceuticals-Announces-Positive-Initial-Data-from-Subjects-with-Type-1-Diabetes-Treated-with-Tegoprubart-as-Part-of-an-Immunosuppression-Regimen-Following-Islet-Transplan.html XX   Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits compared to other diabetes drugs. published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, the study suggests that T2D patients taking semaglutide had a significantly lower risk of developing Alzheimer's. This effect was observed consistently across various subgroups, including differences in obesity status, gender, and age. Semaglutide, which acts on glucagon-like peptide receptors (GLP-1R) to curb hunger and regulate blood sugar in T2D, is also the active component in the diabetes and weight-loss drugs Wegovy and Ozempic. About 120,000 Americans die from Alzheimer's disease each year, with the disease listed as the seventh-leading cause of death nationally, according to the CDC. https://scitechdaily.com/alzheimers-breakthrough-popular-diabetes-drug-ozempic-linked-to-much-lower-risk/ XX   XX Edgepark commercial XX Apple's non invasive blood glucose monitoring rumors are back. But this sounds like just software.. no watch or hardware. According to the report, Apple doesn't currently have plans to release the app, but may integrate the technology into its future health products. The app could reportedly show consumers how certain foods impact their blood sugar levels, based on measurements taken by existing blood sugar monitoring devices. One report says apple is exploring uses for blood sugar data and what tools they could create for consumers as a result. Latterly, he reports testing on the app has been paused, but says the tests could pave the way for better food tracking on Apple's own health software or better third-party glucose tracking integration. https://www.techradar.com/health-fitness/apple-is-testing-a-new-blood-sugar-product-but-its-not-the-apple-watch-update-weve-been-waiting-for XX And finally, it's diabetes awareness month. Please follow on social – I'll be doing a few things but mostly I think this month is great to educate the general public.. every month is diabetes month for this community. XX Join us again soon!

Flytographer Referral Link - Get $50 OFF YOUR FIRST SHOOT! (Valid 10/1-10/31/2024. After that, it's $25 off your first shoot).Chase Sapphired Preferred - ELEVATED OFFER (OCT 2025)World of Hyatt Personal Card - ELEVATED OFFER (OCT 2025)All other best cards for October 2025Follow us on Instagram @TravelPartyof5Tune in to learn:How we used points and miles to book flights and a stay at the Grand Hyatt Kauai.What to expect from the property, including its amenities, dining options, and more.Tips on how to score club access and save money on meals during your stay.Current offers on points and miles cards that can help you book your next family trip.In this episode of Travel Party of Five, we're diving into the first part of our family's recent trip to Kauai, including a detailed review of our stay at the Grand Hyatt Kauai. As always, we're focused on how we used points and miles to make this dream vacation happen—without breaking the bank. We'll walk you through the entire experience, from flights to food to activities, while sharing tips on how to maximize your points and miles to stay at luxury properties like the Grand Hyatt Kauai.We started the trip by using our points and miles to book flights with Southwest, taking full advantage of our Companion Pass to fly our family of five for the price of three tickets. For our stay, we used Hyatt points to book the Grand Hyatt Kauai, a Category 7 property, saving us over $8,000 in cash costs. We'll explain how we secured this luxury stay with just 30,000 points per night and offer tips on making the most of the club access at the hotel, which helped us save on meals during the trip.Our review of the Grand Hyatt Kauai covers everything from the beautiful ocean views and spacious property to the pool areas, which include a lazy river, water slide, and even a lagoon. You'll hear about how the property's location near Poipu Beach provided access to wildlife like Hawaiian monk seals and sea turtles. Plus, we'll share our experiences with on-property dining options, including our memorable meal at Tidepools, and what to expect from the club lounge.We'll also touch on a few mishaps, including a stomach bug that hit one of our kids, which led to some unexpected challenges. Despite this, the Grand Hyatt Kauai provided plenty of space and amenities to make our stay comfortable, even during a family emergency.So if you're looking for practical tips on how to use points and miles to book family vacations at luxury properties like the Grand Hyatt Kauai, or you just want to hear about what it's really like to travel with kids, this episode is for you. Stay tuned for part two, where we'll cover all the fun activities we did in Kauai, and share more about how points and miles made this dream vacation possible.Whether you're a seasoned points and miles pro or just getting started, we hope this episode helps you learn new ways to travel more for less!

Tidepool Pupil has been seen at the scene of some crimes, and I play Concierge Druid on the ladder. You can find the deck import code below the following contact links.  Join our Discord community here or at discord.me/blisterguy. You can follow me @blisterguy or the podcast @walktoworkHS on twitter. Subscribe to my Youtube channel. You can support this podcast and my other Hearthstone work at Patreon here. # 2x (0) Innervate # 2x (1) Giftwrapped Whelp # 2x (1) Go with the Flow # 2x (1) Magical Dollhouse # 2x (1) Seabreeze Chalice # 2x (1) Tidepool Pupil # 2x (2) Bottomless Toy Chest # 2x (3) Splish-Splash Whelp # 2x (3) Swipe # 2x (3) Take to the Skies # 2x (4) Chia Drake # 2x (4) Concierge # 2x (4) Desert Nestmatron # 1x (5) Mistah Vistah # 2x (7) Sleep Under the Stars # 1x (9) Fye, the Setting Sun #  AAECAZveBQLBlQaluwYOrp8Eu5UG15wG2pwG6qgGh7EGlLEG2bEG1boGwr4Ggb8GgMoGgNcG9+UGAAA=

The Perils in Paradise meta has begun to settle down after the most recent balance patch. Join ZachO and Squash as they take a look at how things are looking right now as long as their hopes for an upcoming balance patch. --- Support this podcast: https://podcasters.spotify.com/pod/show/vicious-syndicate/support

Send us a Text Message.Dee and Carol discuss planting perennials in the fall, blackberries, and a book about two women botanists, plus several other topicsFor more information, check out our free weekly newsletter and subscribe to it!Links:Dee's Instagram video about Tidepool zinnias. Carol's All-America Selections grown from seed: Zinnia angustifolia 'Crystal White  Zinnia Profusion  Red Yellow Bicolor, and Coleus Premium Sun Coral Candy. Carol's blog post on her lavender cutbackBlackberry and Raspberry Culture for the Home Garden | Oklahoma State University.On the bookshelf: Brave the Wild River: The Untold Story of Two Women Who Mapped the Botany of the Grand Canyon by Melissa Sevigny. (Amazon Link)Dirt: Your RoundUp herbicide has changed.Rabbit Holes: Carol' s Lost Ladies of Garden WritingOur Affiliates (Linking to them to make a purchase earns us a small commission):Botanical InterestsFarmers DefenseEtsyTerritorial SeedsTrue Leaf Market Eden BrosNature Hills Nursery  Book and Amazon links are also affiliate links.Email us anytime at TheGardenangelists@gmail.com  For more info on Carol  visit her website.  Visit her blog May Dreams Gardens. For more info on Dee, visit her website.  Visit her blog Red Dirt Ramblings.Support the Show.On Instagram: Carol: Indygardener, Dee: RedDirtRamblings, Our podcast: TheGardenangelists.On Facebook: The Gardenangelists' Garden Club.On YouTube.

Monica, Kevin, and Brian discuss what they've been up to in Hearthstone over the past several weeks and take a look at early revealed cards for Perils in Paradise!

The California coast spans 840 miles and boasts diverse flora and fauna. Pat Krug's new book explains why these creatures live where they do, and gives tips on how to spot them.  Scarlett Johansson says ChatGPT's new AI assistance, “Sky,” sounds alarmingly like her. She previously declined a request from OpenAI to be its voice.   Film critic Tim Grierson reviews what's new at Cannes, including works from Francis Ford Coppola and Yorgos Lanthimos. A Donald Trump biopic is also in the lineup.  Alyse Whitney's new cookbook is exuberant, fun, and filled with recipes for all kinds of dips — classics, five-minute ideas, plus light and healthy fare. 

It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: a new study shows that drugs like Ozempic can be produced for just a few dollars, we upate the insulin vial shortage Lilly announced, a new pump has been FDA cleared, a genetically modified cow can product human insulin, and more! Transcript and links below Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com  

Twiist, a newly FDA cleared pump, will automate insulin delivery using Tidepool Loop. Tidepool Loop is an FDA cleared automated insulin delivery app built from the popularly used DIY Loop.    Join Patreon for Exclusive Content   Fill out T1D Exchange Registry    Watch Video Podcast on Youtube    Follow for more: Instagram | Tik Tok | YouTube | Facebook   Send us Feedback & Join the Newsletter   DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care. 

Our website www.perksofbeingabooklover.com. Instagram - @perksofbeingabookloverpod FaceBook - Perks of Being a Book Lover. To send us a message, go to our website and click the Contact button. This week we talk about some of our favorite books coming out of small and independent presses. The Big 5 publishers print those blockbusters we love to stick in our beach bag but smaller presses support much more diverse authors and innovative and important stories that may be your next favorite read! We give you a little primer about the difference between a small press and an imprint by on the Big 5. And we give you 10 books (plus a few more) that we recommend from indie presses! Books mentioned-- 1- The Changeling by Victor Lavalle 2- The Odyssey by Homer 3- Men Explain Things To Me by Rebecca Solnit 4- Everyman by Philip Roth 5- Italian Shoes by Henning Mankell 6- Gilead by Marilynne Robinson - 5 star readrecommended by fellow book lover Amy Bernath @mrsmillardfillmorereads 7- The Wild Hunt by Emma Seckel (Tin House) 8- Three Ways to Disappear by Katy Yocom (Ashland Creek Press) ThePerksofBeingaBookLover.podbean.com/e/ep-3…26-20/ 9- The Salt Fields by Stacy D. Flood (Lanternfish Press) 10- Whiskey and Ribbons by Leesa Cross Smith (Hub City Press) 11- Landings: A Crooked Creek Farm Year by Arwen Donahue (Hub City Press) 12- Places We Left Behind: A Memoir in Miniature by Jennifer Lang (Vine Leaves Press) 13- What Ben Franklin Would Have Told Me by Donna Gordon (Regal House) ThePerksofBeingaBookLover.podbean.com/e/s-6-…-8-22/ 14- Menopause: A Comic Treatment edited by MK Czerwiec (Penn State University Press) 15- Bad Tourist by Suzanne Roberts (Univeristy of Nebraska Press) 16- Another Appalachia by Neema Avashia(WVU Press) 17- World of Wonders by Aimee Nezhukumatathil (Milkweed Editions) 18- Late Migrations by Margaret Renkl (Milkweed Editions) 19- Lungfish by Meghan Gillis (Catapult Books) 20- Tidepool by Nicole Willson (Parliament House) 21- The Keeper of the Key by Nicole Willson (Parliament House Books - coming Nov. 12, 2024) Movies/Shows mentioned-- Maestro (Netflix, 2023) The Changeling (Apple+, 2023) For All Mankind (Apple+, 2019) Links mentioned: Odysseus Lunar Landing - www.cnn.com/2024/02/22/world/mo…nasa-scn/index.html Solar Flare - www.cbsnews.com/philadelphia/news…outage-earth-att/ Human Isolation on Mars- www.nytimes.com/2024/02/25/magazi…n-experiment.html LA Public Library now owns a small press - www.latimes.com/entertainment-art…makes-total-sense

Our website www.perksofbeingabooklover.com. Instagram - @perksofbeingabookloverpod FaceBook - Perks of Being a Book Lover. To send us a message, go to our website and click the Contact button. This week we talk about some of our favorite books coming out of small and independent presses. The Big 5 publishers print those blockbusters we love to stick in our beach bag but smaller presses support much more diverse authors and innovative and important stories that may be your next favorite read! We give you a little primer about the difference between a small press and an imprint by on the Big 5. Books mentioned-- 1- The Changeling by Victor Lavalle 2- The Odyssey by Homer 3- Men Explain Things To Me by Rebecca Solnit 4- Everyman by Philip Roth 5- Italian Shoes by Henning Mankell 6- Gilead by Marilynne Robinson - 5 star readrecommended by fellow book lover Amy Bernath @mrsmillardfillmorereads 7- The Wild Hunt by Emma Seckel (Tin House) 8- Three Ways to Disappear by Katy Yocom (Ashland Creek Press) https://ThePerksofBeingaBookLover.podbean.com/e/ep-35-revision-and-riding-the-tiger-with-katy-yocom-2-26-20/ 9- The Salt Fields by Stacy D. Flood (Lanternfish Press) 10- Whiskey and Ribbons by Leesa Cross Smith (Hub City Press) 11- Landings: A Crooked Creek Farm Year by Arwen Donahue (Hub City Press) 12- Places We Left Behind: A Memoir in Miniature by Jennifer Lang (Vine Leaves Press) 13- What Ben Franklin Would Have Told Me by Donna Gordon (Regal House) https://ThePerksofBeingaBookLover.podbean.com/e/s-6-e-136-a-man-a-boy-a-mom-a-pig-and-ben-franklin-with-guest-donna-gordon-6-8-22/ 14- Menopause: A Comic Treatment edited by MK Czerwiec (Penn State University Press) 15- Bad Tourist by Suzanne Roberts (Univeristy of Nebraska Press) 16- Another Appalachia (WVU Press) 17- World of Wonders by Aimee Nezhukumatathil (Milkweed Editions) 18- Late Migrations by Margaret Renkl (Milkweed Editions) 19- Lungfish by Meghan Gillis (Catapult Books) 20- Tidepool by Nicole Willson (Parliament House) 21- The Keeper of the Key by Nicole Willson (Parliament House Books - coming Nov. 12, 2024) Movies/Shows mentioned-- Maestro (Netflix, 2023) The Changeling (Apple+, 2023) For All Mankind (Apple+, 2019) Links mentioned: Odysseus Lunar Landing - https://www.cnn.com/2024/02/22/world/moon-landing-intuitive-machines-nasa-scn/index.html Solar Flare - https://www.cbsnews.com/philadelphia/news/x6-solar-flare-today-outage-earth-att/ Human Isolation on Mars- https://www.nytimes.com/2024/02/25/magazine/mars-isolation-experiment.html LA Public Library now owns a small press - https://www.latimes.com/entertainment-arts/books/story/2024-01-08/the-l-a-public-library-is-getting-into-book-publishing-why-it-makes-total-sense

This week, addressing something that half of all people with diabetes experience but that there is woefully little information and study about. Why is there so little study about periods and type 1 diabetes? We're talking to two organizations who are teaming up to change that – but they need your help. We're talking about Tidepool's Period Project. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. You'll hear from Martina Rothenbühler, project leader data sciences and data protection officer at DCB, and Maya Friedman, founder of The Period Project at Tidepool. Learn more and sign up for the study here: Menstrual Cycle Study: Identifying changes in insulin sensitivity across the menstrual cycle in T1D - Diabetes Center Berne (dcberne.com) Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com

This week on Gunslinger's Gateway: After collecting their winnings from the Tide Pool fights, the Book Keepers celebrate with a drink (or three) in the Exalted Pig. Some members want to keep the festivities going and set off on a bar crawl, while other members head home to rest and recuperate.

Hello listeners, In this episode we will be talking about tidepools!!! Tidepools are really interesting habitats, and are basically little, exposed reefs!!! Be sure to listen to the episode if you are interested to know more!!!

In this MVP episode with former editor at diaTribe, Adam Brown talks about his experience with diabetes, CGM, mental health, and his work with diaTribe and Tidepool. We also talked about Adam's book, Bright Spots and Landmines. This book is a free resource for type 1 diabetics.Join the Half-Dead Pancreas Club! What to do next... Leave a review on Apple Podcasts Join the Half-Dead Pancreas Club Follow the Pod on Instagram Follow Colleen on Instagram Follow Jessie on Instagram Follow us on TikTok

Chuck Slaughter is the founder of Living Goods, which supports over 10,000 digitally-empowered community health workers who are reducing child deaths by over 25% at an annual cost of under $4 per person. As a Senior Advisor to TPG Rise (a $10 billion impact investing platform), Director of the Horace W. Goldsmith Foundation, and a successful entrepreneur, Chuck has a rich perspective on how digital is reshaping aid and development work. Tune in today to hear Chuck's guidance on whether to ‘build or buy' tech, why nonprofits struggle to deliver the best technology products, and how governments and the private sector need to work together to scale high-impact innovations. Chuck serves on the boards of Yale's School of Management, Tidepool, Reach Health, and the Horace W Goldsmith Foundation. He received a Skoll Award for Social Entrepreneurship, an Ernst and Young Entrepreneur of the Year Award, a Draper Richards Kaplan Fellowship, and is a World Economic Forum Social Entrepreneur of the Year.  A Few Highlights (6m27s) - How Chuck and Living Goods became digital first (13m45s) - The DESC metaphor of Living Goods: Digital, Equipped, Supervised and Compensated (22m01s) - Working with new technologies: the 'build or buy' debate (28m24s) - Why nonprofits struggle to build great tech (32m09s) - The digital transformation of aid: grantmaking through the Horace W. Goldsmith Foundation (37m08s) - Financing scale: how governments and the private sector need to work together (40m19s) - Rapid fire questions, shoutouts, and recommendations You can learn more about Living Goods on their website at livinggoods.org.    Let us know what you thought of this episode on LinkedIn or Twitter (@AidEvolved). You can also access show notes at AidEvolved.com.

Featuring our lives and reactions as we live in a tidepool. --- Send in a voice message: https://podcasters.spotify.com/pod/show/treasurehuntintheword/message

Tidepool Loop is an FDA-cleared version of the DIY Loop automated insulin delivery system and it's ready for users. I speak with Tidepool's CEO, Howard Look, about the future of the app and how patients will use the software with their pumps and cgms.      Listen to the episode Origins of DIY Loop to hear about the incredible story behind Loop and the smart group of people who built one of the first closed loop insulin delivery systems.     Subscribe to this podcast for new episodes every Monday.     Follow for more: Instagram | Tik Tok | YouTube | Facebook   Watch Video Podcast on Youtube    This podcast should NOT be considered medical advice. Always consult with your doctor before making changes to health care treatment.

In this episode of "The Top Line," we talk with Fierce's Andrea Park and Gabrielle Masson about the latest from the American Diabetes Association's annual conference. We also cover a statement about transgender care, light therapy, and the rest of the week's headlines.  To learn more about the topics in this episode: 'Podnosis': Medicaid eligibility determinations, healthcare for the LGBTQ+ community Introducing the Fierce 50: Honoring healthcare and biopharma champions fighting for patient care Lilly links oral obesity drug to 15% weight loss, setting bar for Pfizer in blockbuster battle Boehringer's new data drop shows 19% weight loss for phase 2 obesity prospect UPDATE: Lilly's next obesity drug just cut an average of 58 pounds—prompting an all-out phase 3 blitz Let there be light: Scientists report new progress in quest to treat afib with optogenetics UK's flagging clinical trial sector faces fresh challenge as National Cancer Research Institute set to close Biotech leaders protest 'actively harmful' bans on gender-affirming care Know Labs unveils first prototype of portable, noninvasive glucose monitor Embecta dives deeper into Type 2 diabetes tech with Tidepool team-up Fitterfly's diabetes digital therapeutic cuts blood sugar, weight in real-world trial "The Top Line" is produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts. We'd love to hear from you! If you have a comment about this podcast or if you have a tip for a future episode of The Top Line, you can reach us at this link. See omnystudio.com/listener for privacy information.

Nature is an incredible source of inspiration for scientists and R&D experts, leading to the development of biomimicry: a new branch of science that seeks to imitate living things. Through biomimicry, researchers are able to develop new technologies by studying and imitating the designs created in nature by Allah. This approach has been applied in the world of technology, particularly in nanotechnology, robot technology, artificial intelligence, medicine, and the military. By drawing from these natural systems as models, humans are able to create more sustainable technologies than those in use today. Biomimicry has surprised scientists and revealed incomparable structures and systems that have the potential to enrich technology in a wide range of fields. Nature is a source of inspiration for scientists, and biomimicry is a way of using the extraordinary designs in living things in the service of humanity. Scientists are making important gains with regard to time and labor, and using less material resources by imitating nature. There are many scientific papers that discuss these topics, such as "Science is Imitating Nature," "Life's Lessons in Design," "Biomimicry: Secrets Hiding in Plain Sight," and more. In the 19th century, nature was only imitated aesthetically, but in the 20th century, scientists began studying natural mechanisms at the molecular level and learned from living things, as revealed in the Qur'an 1,400 years ago. Notes: 159. Frederick Pratter, "Stories from the Field Offer Clues on Physics and Nature," Christian Science Monitor; www.biomimicry.org/reviews_text.html 160. "Biomimicry;" www.bfi.org/Trimtab/spring01/biomimicry.htm 161. Michelle Nijhuis, High Country News, July 6, 1998, vol. 30, no. 13, www.biomimicry.org/reviews_text.html 162. "Biomimicry Explained: A Conversation with Janine Benyus," www.biomimicry.org/faq.html 163. Bilim ve Teknik, August 1994, 43. 164. Philip Ball, "Life's lessons in design," Nature 409 (2001): 413-16; www.nature.com/cgi-taf/DynaPage.taf?file=/nature/journal/v409/n6818/full/409413a0_fs.html&filetype=&_UserReference=C0A804EF465069D8A41132467E093F0EDE99. 165. "Biomimicry: Secrets Hiding in Plain Sight," NBL (New Bottom Line) 6, no. 22, November 17, 1997; www.natlogic.com/resources/nbl/v06/n22.html 166. Janine M. Benyus, Biomimicry: Innovation Inspired by Nature (New York: William Morrow and Company, Inc.: 1998); www.biomimicry.org/reviews_text.html 167. Ed Hunt, "Biomimicry: Genius that Surrounds Us," Tidepool, www.biomimicry.org/reviews_text.html 168. Robin Eisner, "Biomimetics: Creating Materials from Nature's Blueprints," The Scientist, July 8, 1991; www.the-scientist.com/yr1991/july/research_910708.html 169. Jim Robbins, "Engineers Ask Nature for Design Advice," New York Times, December 11, 2001.

On today's episode, we are going to talk about designing open source medical software.  Maya Friedman is a digital product design lead and art director who designs solutions for unmet needs in the health tech and femtech spaces. She currently leads the user experience, visual and sonic design for Tidepool's FDA-cleared, automated insulin dosing mobile application, Tidepool Loop. She is also the founder of The Period Project, which supports the creation of an ecosystem of software solutions, research initiatives, and education to address the unmet needs of women+ with diabetes, through the different phases of a woman's life cycle including menstruation and pregnancy. Prior to joining Tidepool, Maya was a creative lead for Allbodies Health, designing education to improve sex, mind and body literacy. She also worked as a creative at Made Music Studios, driving the design and strategy for digital-audio experiences, most notably leading a partnership with the Cooper Hewitt Design Museum to develop an audio-first design exhibition around alarm fatigue in hospital settings. She thrives leading a team of product designers, illustrators, user researchers and sound designers to design solutions for topics such as health and body literacy, menstrual health and alarm fatigue. Maya has her MFA in Media Design practices with a focus on femtech and sextech design from ArtCenter College of Design. Kelly Watson is VP, Product & User Experience for Tidepool, a digital health nonprofit building solutions for people with diabetes. Kelly has worked to ensure the patient, the clinician and care partners are at the center of the product design process, leading Tidepool to achieve rapid market adoption growing its global ecosystem to over 450,000 people with diabetes and 12,000 clinicians. At Tidepool, she has led partnerships with many of the world's largest diabetes medical device companies and technology companies. Previously Kelly worked in bench research at the Center for Biologics Evaluation and Research, FDA (CBER-OVRR DVP) and the National Institute of Mental Health prior to building out a product design consultancy. She is an angel investor and advisor for emerging digital health startups. Kelly advocates for patient ownership of health data, interoperability and open healthcare standards. Episode mentions and links: https://www.tidepool.org Tidepool loop has received FDA clearance Tidepool loop origin story Tidepool: Ways to give Maya's restaurant rec: Saffy's Kelly's restaurant rec: Hook Fish Co. Follow Maya: LinkedIn | Instagram Follow Kelly: LinkedIn | Twitter Episode Website: https://www.designlabpod.com/episodes/117

This is Dr. Travelbest's Guide In this episode: FAQ is: Who sets the standards for airline seats? Today's Destination is: Point Loma, San Diego Today's Lesson Learned- I forgot the tent poles. Travel Advice:  Join the US STEP program if you plan to travel out of the country in the next year.   FAQ: Rebecca asks, Do the airline seats seem to be getting smaller these days? Am I the only one who sees or feels this happening? I would like to know. Also, please give me information on how much space should be on a plane for my seat. I'm struggling with this issue now. Who sets the standards for airline seats?   Answer: Dear Rebecca, You are being heard. I'm so glad you asked. I've wondered the same thing. In the USA, The Federal Aviation Administration is looking at a rule for minimum amounts for the width of airplane seats and the distance between the front of one seat and the back of the seat ahead.  They are gathering public comments on the issue now. Their concern is safety. If seats are too small, it can hurt evacuations in an emergency. How is your legroom? We want to hear from you now, so contact the FAA to give them your concerns. Today's destination: Point Loma, San Diego   Point Loma is a land mass that sticks out in the Pacific Ocean, a large peninsula; on the water, you can't go from Downtown San Diego without bumping into this point. So it was one of the first places to land for settlers in the land.    Why visit Point Loma? The National Park, Cabrillo National Monument, and the lighthouse are the most famous places to visit as a traveler. This is one best viewpoints for the entire city and region. You will want to spend a half day exploring nature and the visitor center. You can see inside the lighthouse and climb the stairs to see what it was like to live there hundreds of years ago. I highly recommend this destination.   You can see Mexico, downtown, and a lot of ocean from here. Tonight, I met a couple from Lexington, Kentucky, and they visited the lighthouse today. They raved about the experience of being in the home that was a lighthouse and being able to see afar.   The tidepools are also worth seeing. If you have never been to a tidepool, it's when the ocean tides recede, and you can see the small sea creatures like starfish and crabs among the nooks and crannies of the rocks on the beach, walking carefully not to disturb wildlife.    My favorite place to eat fresh seafood locally is Point Loma Seafoods. My favorite Coffee shop is Peet's. My favorite YMCA is Ryan Family Y. My Favorite thrift store is Goodwill San Diego. Point Loma has Sunset Cliffs Blvd, which has great views and sunsets. You can swim here, too, if you can navigate the hike safely. However, it's not meant for the faint of heart, as swimming here is not as safe. It's better to head north to the public beaches. You'll also see beaches just for dogs, and dozens of them running around the sandy beach.   You'll be in Ocean Beach, which is a community next door, almost connected.    My first visit was in 1982, as I was relocating from Chicago. Little did I know how this part of the region would impact my life when I prayed in my car that day. I said out loud, “Lord, if it is meant to be, find my subsequent work and life in this city. So I prayed in my car, parked on Cornish Drive, a block from where I lived a few months later. Yes, the same street, about a block from where this prayer happened. And it turned out great for the past several, well, 40 years, it's been. Today's Mistake- Forgot the tent poles   I was camping in Nevada along a beautiful river. I brought my tent but forgot to bring the tent poles. So, I slept under the stars. It was decent weather that night, so pretty good. Don't forget your tent poles as I did.    Today's Travel Advice-Join the US STEP program if you plan to travel out of the country in the next year.   I joined the US STEP program in 2023, and they will inform me when I travel abroad and see a problem in a country I visit. Also, they will have my information if I need to contact them, making it easier to find and help me. They help people with problems. I hope I don't need to contact them, but better safe than sorry.

This episode features an interview with Howard Look, CEO and co-founder of Tidepool, a non-profit organization that has a range of software tools for people with diabetes and the clinics that serve them. Tidepool recently received US Food and Drug Administration (FDA) clearance of Tidepool Loop, an automated insulin dosing app meant for the management of type 1 diabetes in patients who are six years of age and older. Howard spoke about the FDA clearance and discussed how Tidepool Loop addresses an unmet need in the type 1 diabetes space.Howard shared his story about his personal connection to diabetes and what prompted him to start Tidepool. He discussed his strategy for engaging stakeholders — the patients, health care providers, caregivers and payers — to pave the way for individuals with type 1 diabetes to access Tidepool Loop.Hear more about Tidepool Loop and Tidepool's continuing work in the diabetes management space.Read more here:Tidepool Loop Is FDA Cleared as an Automated Insulin Dosing App for Type 1 DiabetesFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

For Adam Summers, natural history and the practice of biomechanics starts with those moments where you witness an animal or plant doing something that you can't quite understand.  How did that eagle fly upside down? How did that fly land on the ceiling? How did that suckerfish stick to that rock?  I find Adam to be one of the most captivating communicators of science and enthusiastic curiosity I've ever encountered, I think you will too. See his bio below and find his Twitter profile here.  Adam Summers is a professor in the department of Biology and in the School of Aquatic and Fisheries Sciences at the University of Washington. He now runs the comparative biomechanics and biomaterials lab at the University of Washington's Friday Harbor Labs. Current research topics include the evolution and mechanical properties of cartilage and tendon, swimming mechanics of sharks, respiratory patterns of sharks and rays and solid-solid interactions in aquatic organisms. This work has led to more than 90 publications and two patents. He has consulted on films (including one of my personal favorite movies, Finding Nemo), television and for 8 years his monthly column in Natural History Magazine – ‘Biomechanics', brought comparative biomechanics to a wider audience. 

ChatGPT and large language models offer physicians the chance to do what they went to medical school for: connect with patients and help them regain their health. This podcast is intended for US healthcare professionals only. To read a full transcript of this episode or to comment please visit: https://www.medscape.com/features/public/machine Eric J. Topol, MD, Director, Scripps Translational Science Institute; Professor of Molecular Medicine, The Scripps Research Institute, La Jolla, California; Editor-in-Chief, Medscape Aaron B. Neinstein, MD, Associate Professor, Department of Medicine, University of California, San Francisco; Vice President, Digital Health, UCSF Health, San Francisco, California Our AI Future is Better Than You Think: https://www.nature.com/articles/s41591-022-02021-9 Tidepool: https://www.tidepool.org/ You may also like: Medscape's Chief Cardiology Correspondent Dr John M. Mandrola's This Week In Cardiology https://www.medscape.com/twic Discussions on topics at the core of cardiology and the practice of medicine with Dr Robert A. Harrington and guests on The Bob Harrington Show https://www.medscape.com/author/bob-harrington For questions or feedback, please email: news@medscape.net

Dr. Saleh Adi is a pediatric endocrinologist and the Co-Founder and Chief Medical Advisor at Tidepool.org. Dr. Adi speaks with Scott about insulin delivering algorithms and type 1 diabetes management ideas. Episode 541, Dr. Saleh Adi was first published on Sep 13, 2021. Grace has type 1 diabetes and body dysmorphia. Try delicious AG1 from Athletic Greens Use code JUICEBOX to save 35% at Cozy Earth  Get the Gvoke HypoPen CONTOUR NEXTONE smart meter and CONTOUR DIABETES app Learn about the Dexcom G6 and G7 CGM Go tubeless with Omnipod 5 or Omnipod DASH  Get your supplies from US MED  or call 888-721-1514 Learn about Touched By Type 1 Take the T1DExchange survey A full list of our sponsors  How to listen, disclaimer and more Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The show is now available as an Alexa skill. My type 1 diabetes parenting blog Arden's Day Listen to the Juicebox Podcast online Read my award winning memoir: Life Is Short, Laundry Is Eternal: Confessions of a Stay-At-Home Dad The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! Follow Scott on Social Media @ArdensDay @JuiceboxPodcast Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find the show and consider leaving a rating and review on iTunes. Thank you! Arden's Day and The Juicebox Podcast are not charitable organizations.

It's In the News, a look at the top stories and headlines from the diabetes community happening now. This week, Dexcom sets a US release date for the G7, we find out whether Tandem will be a Tidepool Loop partner now that Insulet and Medtronic are out, Omnipod Eros to be discontinued, a new study says there's a better age to test kids for type 1, a new smart insulin pen sensor can also be used to track dosing of GLP-1 medications, a new twist in the Faustman study of the TB vaccine to treat diabetes, the Sims 4 update brings CGMs to the game and more. Links and transcript below Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode Transcription:  Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines happening now XX In the news is brought to you by VIVI Cap – confidence on the go that keeps your insulin protected in hot or cold XX Learning a bit more about the Tidepool pump partnership, at least who it won't be. When Tidepool Loop approval was announced last month, it came without the original pump partners, Omnipod and Medtronic. CEO Howard Look said they do have a pump partner but that they're not ready to announced yet. I spoke to Tandem for next week's episode and they say its' not them. Quote “That's not part of our roadmap, it's not an integration we're working on.” XX Insulet announces it will discontinue the original Omnipod system. In a letter to healthcare professionals, the company says the system, referred to as Eros or Omnipod Classic will be discontinued at the end of this year. It's no longer available to new patients and existing customers will be transitioned to Dash or Omnipod 5. I'll link up the letter in the show notes. “Dear healthcare professionals, We have made the decision to discontinue the original omnipod insulin management system in the us after December 31 2023. This system is often referred to omnipod eros or omnipod classic. Insulet will continue to support the omnipod system throughout this year to allow existing patients ample time to transition to newer omnipod technology such as Omnipod dash or Omnipod 5. please note this product is no longer available for new patients in the US. After December 31, 2023 Insulet will not be able to guarantee the availability of the omnipod system supplies. “ https://www.facebook.com/photo/?fbid=10225188520677483&set=a.1253748061199 XX Civica continues to move ahead with more affordable insulin, announcing that Ypsomed will make and supply their pens. Civica plans to produce three insulin biosimilars priced at no more than $30 per vial and no more than $55 for a box of five pen cartridges. Contingent on FDA approval, Civica anticipates that its insulins will be available for purchase beginning as soon as 2024. XX New study shows screening kids at risk for type 1 diabetes only once – at age ten – is very effective in detecting the condition by the age of 18. These researchers also say “Almost no one” who is islet autoantibody negative at age 10 years despite a high familial risk for type 1 diabetes will develop clinical diabetes by the age of 18. Full study published in the Lancet. https://www.medwirenews.com/diabetes/age-10-years-optimal-type-1-diabetes-screening-point/23957596 https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(22)00350-9/fulltext?fbclid=IwAR2kRNyGg6lnq3ZWsFkXnCvkeNiisg9mE2bbN_OnGiLrUpcHKXAaff3OkE4 XX The nonprofit public health advocacy group the Physicians Committee issued a formal complaint that a recent CBS "60 Minutes" segment was a promotion for Novo Nordisk's obesity drug, Wegovy, that was dressed up as a news segment. The Washington, D.C.-based group has filed a complaint with federal bodies alleging that the CBS "60 Minutes" segment that aired on New Year's Day breached the FDA's “fair balance” rules for drug ads. The Committee said in a release that the feature failed to talk about alternatives to the drug or about other weight-loss methods; that only experts “paid by Novo” were used in the program; and that the piece used overly promotional language. This has caused Wegovy supply issues for Novo which, coupled with manufacturing problems, only deepened bumps in production last year for the drug and led to an official shortage of the drug in 2022. A spokesperson for Novo Nordisk told Fierce Pharma Marketing: “Novo Nordisk did not provide any payment or sponsorship to CBS 60 Minutes for their reporting on obesity as part of a news segment that aired on January 1, 2023, and we did not control any of the content or have any role in identifying or selecting the doctors and patients featured in the news segment.” https://www.fiercepharma.com/marketing/health-group-lambasts-novo-nordisk-60-minutes-paid-news-program-weight-loss-med-wegovy XX Some researchers have pulled out of a trial investigating the use of an old tuberculosis vaccine to treat children with Type 1 diabetes only months after they began enrolling participants. This is part of the Faustman study of the BCG vaccine. Some recent research suggests that the vaccine, first administered in 1921, also may protect against Covid-19 and respiratory diseases because of its broad effects on the immune system. The lead investigators of the pediatric trial are proceeding with the study, but N.Y.U. Langone's abrupt withdrawal could potentially jeopardize its viability if they are unable to collect data on the children at the N.Y.U. site. An earlier study by the scientists at Massachusetts General found that two doses of B.C.G. vaccine reduced blood sugar levels to near normal in a very small group of adults with Type 1 diabetes. Other studies of B.C.G., using different versions of the vaccine and following Type 1 diabetes subjects for varying periods of time, have yielded mixed results. The lead investigator of the trial, Dr. Denise Faustman, director of the immunobiology laboratory at Massachusetts General Hospital, said that N.Y.U.'s withdrawal was a serious deviation from trial protocol that may call into question the final results. https://www.nytimes.com/2023/01/20/health/diabetes-bcg-nyu.html XX A new smart insulin pen sensor can also be used to track dosing of GLP-1 medications. Brand names for GLP-1 medications include Trulicity and Ozempic. This device, called Mallya, attaches to the injector and connects it to a mobile app. It's already cleared in Europe and should be available in the US in the next few months. The device is compatible with most popular insulin pens, including Lilly's Kwikpen, Sanofi's Solostar, and the Novo Nordisk FlexPen. Biocorp also announced that it has partnered with Novo Nordisk, Sanofi, and Roche Diabetes Care to improve Mallya's current design moving forward. According to the Mallya website, the device's lifespan is two years before a replacement is needed, and in no way does it change the way that users operate their insulin pen. The device can be charged via USB and, with average use of three to four injections per day, requires charging once a month. Also, for those who have different pens for multiple types of insulin, the app can connect multiple Mallya devices, one for basal insulin and another for bolus, for instance. https://diatribe.org/fda-clears-smart-injector-pen-device-mallya XX Tempramed/ VIVI Cap XX New features popped up this week in the latest version of The Sims – after an update, players can opt for their characters to wear a CGM – Libre or Dexcom Freestyle Libre in the Sims 4 game. Search for CGM or Libre XX The Jonas Brothers officially have a star on the Hollywood Walk of Fame. On Monday, Nick, Joe and Kevin Jonas were honored during a ceremony on Hollywood Boulevard where their careers as musicians were celebrated. Their star was dedicated in the category of Recording and the trio was introduced by Monte and Avery Lipman of Republic Records, Ryan Tedder and writer and producer Jon Bellion. While the brothers still maintain their own separate projects -- Nick Jonas is set to produce and star in the upcoming film "Foreign Relations," Joe Jonas recently starred in the film "Devotion," and Kevin Jonas hosts the ABC series "Claim to Fame" -- they continue to make music together and are slated to release new songs this year. The group closed out Monday's ceremony by announcing big news about their upcoming new album, which will be released in May. They also said they'll be going on tour again. XX On the podcast next week.. Tandem Diabetes with an update on their road map announced last year. They've since acquired a patch pump company and one that makes infusion sets. A lot to catch up on! This past week's long format episode is with Tidepool Loop, a deep dive into what was approved with CEO Howard Look That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.

The Juicebox Podcast is excited to bring you Episode #838 - A Look at Tidepool Loop with Howard Look. Howard is passionate about making a positive impact on the world and his company, Tidepool, which he founded and runs as President and CEO, is an example of this. In this episode, we'll get an exclusive look at how Tidepool Loop has evolved and explore the ways it is impacting people's lives. Tune in for a fascinating conversation about how one idea created a ripple effect that changed the lives of many! Try delicious AG1 from Athletic Greens Use code JUICEBOX to save 35% at Cozy Earth  Get the Gvoke HypoPen CONTOUR NEXTONE smart meter and CONTOUR DIABETES app Learn about the Dexcom G6 and G7 CGM Go tubeless with Omnipod 5 or Omnipod DASH  Get your supplies from US MED  or call 888-721-1514 Learn about Touched By Type 1 Take the T1DExchange survey A full list of our sponsors  How to listen, disclaimer and more Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The show is now available as an Alexa skill. My type 1 diabetes parenting blog Arden's Day Listen to the Juicebox Podcast online Read my award winning memoir: Life Is Short, Laundry Is Eternal: Confessions of a Stay-At-Home Dad The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! Follow Scott on Social Media @ArdensDay @JuiceboxPodcast Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find the show and consider leaving a rating and review on iTunes. Thank you! Arden's Day and The Juicebox Podcast are not charitable organizations.

The US FDA has approved Tidepool Loop, an app designed to automate insulin dosing. Born out the do-it-yourself, "we are not waiting" movement, it has designs and features not in the first wave of commercial automated systems like Omnipod 5 and Tandem's Control IQ. CEO Howard Look talks to Stacey about what was approved here and what Tidepool Loop is all about. If you've followed this story closely, you're going to be surprised to learn about a few changes that have happened along the road to approval.. and to learn the questions that Tidepool will have to answer next. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Learn more about Tidepool: https://www.tidepool.org/ Our previous episodes with Howard Look:  Please visit our Sponsors & Partners - they help make the show possible! Take Control with Afrezza  Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com    

In this episode of Diabetes Dialogue, ours hosts discuss the clearance of Tidepool Loop, what is unique about the app's customizability and compatibility with other diabetes technologies, and other top points for people with diabetes and members of the diabetes care team to consider with the technology moving into the future. Check out the video version here.

This week on Pharm5: Amazon's RxPass Subscription Brenzavy (bexagliflozin) for T2DM Leqimbi (lecanemab) for mild Alzheimer disease Vaccine efficacy for Omicron XBB TidePool Loop app cleared by FDA Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: Gupta V. Introducing RxPass from Amazon Pharmacy, a $5 prescription subscription that helps prime members who take multiple medications save time and money. US About Amazon. http://bit.ly/3ReGKhE. Published January 24, 2023. Accessed January 26, 2023. All RxPass medications. http://bit.ly/3kN8628. Accessed January 27, 2023. FDA grants accelerated approval for Alzheimer's disease treatment. U.S. Food and Drug Administration. http://bit.ly/3HxSkRI. Accessed January 26, 2023. Lecanemab. Lexi-Drugs. Hudson, OH: Lexicomp, 2015. http://bit.ly/3DeqR4X. Accessed January 26, 2023. Park B. Brenzavvy approved for adults with type 2 diabetes. MPR. http://bit.ly/3DjPME3. Published January 23, 2023. Accessed January 26, 2023. Early estimates of bivalent mrna booster dose vaccine effectiveness in preventing symptomatic SARS-COV-2 infection attributable to omicron ba.5– and XBB/XBB.1.5–related sublineages among immunocompetent adults - increasing community access to testing program, United States, December 2022–January 2023. Centers for Disease Control and Prevention. https://bit.ly/3kRkMos. Published January 25, 2023. Accessed January 26, 2023. NCIRD Surveillance Systems. Centers for Disease Control and Prevention. https://bit.ly/3wzcfti. Published January 17, 2023. Accessed January 26, 2023. Groundbreaking: Tidepool Loop receives FDA clearance. Tidepool. http://bit.ly/3kFRtoR. Accessed January 26, 2023. Briskin A. Tidepool Loop cleared by FDA. diaTribe. https://bit.ly/3XH2mFL. Published January 26, 2023. Accessed January 26, 2023.

That Owen moment was pretty fucked up

A Pacific Northwest camper, hiker, fisher, and ocean swimmer. That's the growing-up bio of Aiyesha Christian. And being the super outdoors person, Aiyesha also was obviously a big consumer of trail mix to keep her nutrition gauge from going empty. But the trail mix she found was just too dull; either too much salt or too much sugar, always the same ingredients and definitely not enough flavor. Aiyesha loved her outdoor life and wanted all the diversity, flavors, freshness and spirit to be reflected in the food she put into her body, especially when she was on the outdoor trails – being a nomad of course. She had the food background to begin her venture, having worked in restaurants and having tended bars. She began the grand experiments in her kitchen and her friends and family ooed and ahhed over her creations. Some of them also steered her to the Oregon State University's Food Innovation Center in Portland, Oregon and straight to the Director, our show host Sarah Masoni. Sarah was duly impressed with the great taste of the trail snacks and immediately encouraged Aiyesha to continue with the recipes and learn how to commercialize her products so that more people could share in her discovery and the Nomad company began to take shape. One of her first big wins was being part of the Food Innovation Center's holiday markets, where she became introduced to Market of Choice, one of our show sponsors, and got signed on to be displayed on their shelves. Each flavor of Nomad mix has its own special story, Tide Pool to represent the coast, Forest for the woods and so forth. But Aiyesha has a guideline for each product and flavor. Each bag contains at least one type of seed, nut, fruit, and vegetable. It is gluten free, paleo, and almost vegan except for locally sourced honey as the only added sweetener. All the snacks are great to share with your pet, but Aiyesha is contemplating a pet line of snacks as well. So why this foyer into the saturated market of trail snacks, a market that is old, dominated by big food companies that bought up all the small ones years ago and have all the shelf space already taken? In one of her Masters of Business classes, Aiyesha was introduced to the book, Blue Ocean Strategies, that talked about finding new opportunities in old, stodgy markets. This gave her the insight to find her new opportunity and she is making the most of it. Her packaging is exquisite and truly reflects the mission of her company, and the website is impressive. Grocery store shopping is localized in the Pacific Northwest currently, but all products are available online. And in alignment with Aiyesha's love of the outdoors, Nomad gives a percentage of profits to partnered organizations that focus on the protection, rejuvenation, and integrity of our precious communities and environments. Website: www.nomadmix.com, questions: Info@nomadmix.com, IG: @nomadsnackmix. Our hosts: Twitter - @sarahmasoni and @spicymarshall Instagram - @masoniandmarshall.

Spencer Marley is a ‘vegan hunting guide', preserving the history of seaweed foraging along the California coast. By Susan B. Barnes at VegetarianTimes.com. Original post: https://www.vegetariantimes.com/travel/seaweed-foraging-san-luis-obispo/  Tour Link on Airbnb Experiences    Vegetarian Times has been the plant-based lifestyle authority since 1974, sharing recipes and news for vegans, vegetarians, and the veg-curious. They have an online platform at VegetarianTiimes.com and you can join as a free or paid member and receive meal plans, fitness plans & courses, cooking courses and challenges, and just a huge wealth of services, and create your own personalized feed. They offer an incredible amount of content and services, and whether you sign up as a free or paid member, you can create a personalized feed for information that interests you.     How to support the podcast: Share with others. Recommend the podcast on your social media. Follow/subscribe to the show wherever you listen. Buy some vegan/plant based merch: https://www.plantbasedbriefing.com/shop    Follow Plant Based Briefing on social media: Twitter: @PlantBasedBrief YouTube: YouTube.com/PlantBasedBriefing  Facebook: Facebook.com/PlantBasedBriefing  LinkedIn: Plant Based Briefing Podcast Instagram: @PlantBasedBriefing   #vegan #plantbased #veganpodcast #plantbasedpodcast #plantbasedbriefing #vegetariantimes #hunting #foraging #seaweed #wakame #kombu #nori #oliverockweed #grapestone #sealettuce #ramen #tidepools #sanluisobispo #sustainableforaging #phycology #algae  

Content Warnings for this episode: Police interaction, Arrest, Stolen and appropriated cultural items, Smoking ------------------------------------------------ Our Crew of the Bois Perdu docks in the majestic Merchant's House of Paraiso Eliminado. Food, drink, and pleasure are not on the agenda this time. Rather, their sights are set on a merchant named Sergio and the treasure he's reportedly trying to trade. ------------------------------------------------ To my dearest Captain Hano, My thorned rose, if the whispers that dance to me on the waves of the sea speak truth, then you and your crew have indeed survived. If that is the case then I send up every song in my heart to the Goddess that this letter reaches you safely. My mind reels imagining what feats of swashbuckling daring-do you managed to pull off allowing your escape from those blasted Bluecoats. What I would give to one-day bear witness to such skill and panache. Though I fear with my constitution in the state that it is, the mere sight of blood would see me laid out upon the deck like the many fools who meet the business end of your trident. Forgive me, for I seem to have found myself rambling. I know how your days and nights are filled with endless adventures. So, I will neither waste words nor ink and find myself to the point swiftly. There is a deal taking place in Paraiso Encontrado on the 13th of Blooming Tides. A merchant by the name of Sergio Diez De Laton has been making waves around the Shark's Tidepools recently. He's Petite Espenoran nobility, known for his ever-growing collection of "Pirate History". He apparently considers himself an academic of a sort. Recently he's been searching for a buyer for one of many objects in his prized personal collection, an unusual circumstance.  Not sure what the item is specifically, but word has it that it once belonged to one of the old Pirate Lords. And I mean one fo the OLD Pirate Lords. One of the first. If this is the case then I would say it's most likely better in your hands than theirs or their buyers. I won't lie, I yearn for the whispers I'm sure to hear if you choose to act on this information. Tales of intrigue and insidious skullduggery. They'll act as a fleeting panacea to dull the agonizing pain of being so far from your tender touch. Forever yours, Lady Brienne Campbell ------------------------------------------------ Hosted and GM'd by Kendrick Smith (@KendoMakesFilms) Featuring: Dr. Hilda as Avery Morrigan Marcie (@SoapieSquid) as Brynn Theriot Gus (@AugustKnobbe) as Felix “Lunulata” Cormier Ellis (@Whore_Or_Writer) as Thorin and Eldoris Music from: Epidemic Sound  Editing by: Zach Zito (@_SpaceLung_)  ------------------------------------------------ Follow us on Twitter and Instagram for updates and additional content! You can support the show by checking out our merch at: merchyetsold.com Join our growing community Discord server! Proudly members of the Be Gay Roll Dice podcast network! Discord link You can email us at talesyettoldpod@gmail.com for comments, questions, or feedback. Be safe, drink some water, and don't forget to love yourself like we love you!

As the tide rises and falls each day, it leaves behind salty pools of ocean water in rock depressions near the shore. Though these tidal pools are quite small—and can be harsh habitats—they contain amazing, varied ecosystems. Join Katy Laura as they explore the four tidal zones and the incredible species that live there in this week's episode.Support the show

Top stories in this news this week: Stem cell research Vertex company buys Viacyte, another company looking at stem cells for a functional cure for T1D, some tslim users are getting access to Tandem's new mobile bolus feature, One Drop shows a "health sensor" on its website, a study shows that screening for type 1 at very young ages could help detect most cases and much more! Learn more about the T1D Exchange: https://t1dexchange.org/stacey/ Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM* Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines of the past seven days. XX In the news is brought to you by T1D Exchange! T1D Exchange is a nonprofit organization dedicated to improving outcomes for the entire T1D population. https://t1dexchange.org/stacey/ XX Our top story this week, Vertex buys Viacyte! For context, Vertex is the company that got all the headlines last fall – big article in the New York Times for a stem cell therapy that brought one person with type 1 off insulin completely. The FDA put them on hold but lifted that just last week. Vertex previously acquired Dr. Doug Melton's Semma. Viactye is the company featured in the documentary "The Human Trial" - they're using CRISPR technology to keep the body from rejecting their stem cells. Both companies technology does NOT require immunosuppressive drugs and both say they are working toward a functional cure. Some experts are saying this will speed up that effort while critics worry that it eliminates the competitive aspect of the race. Sernova is still one separate company that has shown stem cell therapy can work.. I've got requests out to Viacyte to talk to us about all of this, so stay tuned. https://investors.vrtx.com/news-releases/news-release-details/vertex-acquire-viacyte-goal-accelerating-its-potentially?fbclid=IwAR15qlFSBsBR89blzXymyIGL3tW5C64QtdHpwq7a5fdjmv2q6JmfoTIpm-k XX If we widely screened kids for type 1 at certain ages, a new study suggests, it would identify most of those who go on to develop it by their teen years. These researchers looked at screening for the type 1 autoantibodies at ages 2 and 6. This included nearly 25-thousand children from Europe and US. One issue in this study, funded by JDRF, all the participants in the combined dataset had genetic risk factors for the disease or a relative with type 1 diabetes, in whom performance is expected to be higher. It also included almost exclusively kids of northern European ancestry. https://www.medscape.com/viewarticle/976992 XX Tandem bolus by phone is slowly rolling out. This week, the T:Connect app was updated in the The t:connect app was updated and emails started arriving for those notified they were part of the early release groups. I did see some reports of people not yet getting the email but seeing the update in their portal so be sure and check. Mobile Bolus is reportedly available for those using Control IQ and Basal IQ. It's worth noting that for those outside the US there really is no timeline, but Tandem has previously said they're going to replace t:connect with a new system that will debut outside the US first. By the way, I got my email this morning, but Benny is still at camp for three more weeks so it'll be a bit before we do the update! XX Interesting look at teens and young adults with type 1.. the early morning psychosocial state may explain a proportion of their daily variance in time in range. The study included 88 participants aged between 14 and 26 years, 56-percent of whom were women. This is tough to quantify but they had the participants complete an engagement prediction survey and set a diabetes management goal for the day when they woke up, and also completed an evening survey. These questions were about mood, motivation, control beliefs, social support, stress, general health, self-esteem, and perceived need for assistance. Of note, lower morning glucose levels correlated with measures of good sleep, high motivation, and good health, whereas higher morning glucose levels were associated with illness and feeling the need for support. https://www.medwirenews.com/diabetes/morning-mindset-daily-glucose-fluctuations-young-people-diabetes/23255450 XX Good catch by our friend Nerdabetic over on Twitter.. One Drop plans to enter what they're calling the continuous health sensing market with a daily disposable, minimally invasive biosensor in development. They say this is designed to provide greater flexibility and insights for people living with diabetes compared to blood glucose monitor (BGM) fingersticks alone. The availability of our continuous health sensor is subject to receipt of clearance or approval from the U.S. Food and Drug Administration. Pending regulatory approval and commercial adoption, we believe integrating the One Drop health sensor with our existing digital solution, One Drop Premium, should augment proven outcomes and yearly cost savings for members living with diabetes and other chronic conditions. https://onedrop.today/blogs/blog/bgm-vs-cgm?utm_source=twitter&utm_medium=social-organic&utm_campaign=social-campaign_jul-2022&utm_content=blog XX Navitus Health Solutions, which is owned by Costco & SSM Health – has joined CivicaScript as a founding member. CivicaScript was created in 2020 to bring affordable versions of common but high-priced generic medicines to market. Earlier this year they announced they would be adding insulin to that list, but it likely won't be available for at least two years. This partnership would seem to insure the lower cost insulin will be available at Costco pharmacies, which you don't have to have a membership to use. https://www.businesswire.com/news/home/20220713005349/en/Navitus-Health-Solutions-Joins-CivicaScriptTM-to-Further-Availability-of-Lower-Cost-Generic-Medications/?fbclid=IwAR0vBF0YlCo9ZJ-9Yd0nLag_Mjuf8s4YpnR9IJVudvVGDR1Rj508HSd_kXw XX Right back to the news in a moment but first As I mentioned, The T1D Exchange Registry is an online research study, designed to harness the power of individuals with type 1 diabetes. It's a research study conducted online over time, designed to foster innovation and improve the lives of people with T1D. Personal information remains confidential and participation is fully voluntary. Once enrolled, participants will complete annual surveys and have the opportunity to sign up for other studies on specific topics related to T1D. By sharing opinions, experiences and data, patients can help advance meaningful T1D treatment, care and policy Sign up at T1DExchange.org slash Stacey (that's S-T-A-C-E-Y). XX The Food and Drug Administration received more than a thousand comments—mainly from diabetes patients and their family members—in response to draft cybersecurity guidance. These are for staff to use when processing submissions from medical-device manufacturers. “Please do not let medical device manufacturers use cybersecurity as a pretense to prevent me from accessing my OWN devices,” reads one entry from a sample of the comments FDA posted to the docket on the guidance. Howard Look, CEO of Tidepool is quoted in some of the article around this. Tidepool provides software that allows patients to see their data and better manage the disease. And supporters are working to make Tidepool Loop the first FDA approved app for more convenient automated insulin delivery. “Following best practices for cybersecurity does not need to imply blocking patient users from accessing their own data or controlling their own devices,” the comments read. “Tidepool asserts there is a risk that the FDA guidance will be interpreted or misinterpreted to suggest restriction of access by the patient user is appropriate or encouraged. The FDA can mitigate this risk by clearly stating a patient user's access to and use of their own device can be considered authorized access, and should not be considered a cybersecurity threat.” With a 90-day public comment period ending Thursday, the FDA will now begin the process of finalizing cybersecurity guidance for its pre-market submissions, according to a notice in the Federal Register. https://www.nextgov.com/cybersecurity/2022/07/diabetes-patients-flood-fda-comments-cybersecurity-medical-devices/374020/ XX Congrats to the team over at Divabetic Podcast – which celebrates 12 years this month! Divabetic was inspired by the late R&B legend, Luther Vandross, and founded in 2005 by his long-time assistant, Max “Mr. Divabetic” Szadek. It's now a national nonprofit organization that uses highly engaged, non-traditional virtual programs, videos and podcasts to promote prevention, early action and education. Congrats to Max and the entire team! https://divabetic.org/about-us/ XX Next week you'll hear from the folks at Diabetes Wise – that's a website to help you choose diabetes technology.. they've added information for doctors – this may help you educate your heathcare providers on why you want the pump or cgm system that you do.. the long format episode out right now is all about campviews, a new system that lets diabetes camps see every camper's CGM all at once. Listen wherever you get your podcasts That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.

Jack dives into the tidepool. Mitzka gets ambushed by sand, and then Klakkr and Moriarty give her drugs. Zachariah helps Jack explore the watery crypt beyond the tidepool… leading to a puzzle with consequences that they could not have seen coming.

Burnout is a serious, often overlooked, issue in the workplace. It affects our mood, our performance at work, but most importantly our relationships and overall mental health.Joining me for this very important episode was Mr. Manny Hernandez, the VP of Community & Partnerships at Thrivable. With a Masters in Engineering, Manny has Led a storied career working for the likes of Procter and Gamble Full Sail and the Diabetes Hans Foundation earlier on his career and having helped build culture and teams at great companies like Livongo (now known to the market as Teledoc) and Tidepool.He is passionate about the Diabetes community and regularly serves as an Advocate, Public Speaker, and Consultant in this space.In 2021 Manny made the decision to take a Sabbatical until just recently when he began serving as the VP of Community & Partnerships for a company called Thrivable which is a real-time market research platform.The organization helps patients and solution-makers work together to create the next generation of products and services.During his Sabbatical he ready over 80 books and discovered a variety of things about life and about himself that I'm sure he will share insights into during our conversation!Some highlights of what we discussed:-What were some lessons learned during your time away?-What would you say to those who would love to do the same, but can't afford to financially? Alternatives for similar effect?-If you had to do if over, would you do it again? Anything differently?-How did you know it was time to come back to FT work?....and so much more!

This week the boys sit down with Nick's Mom and talk about: Pismo, Woolys, Airbnb, Cracked Crab, Campfire, San Louis Obispo, Central Coast Winery, Wine, Barrel House Brewing Company, Tidepools, Bad Italian food, Santa Barbara, Institution Ale, Lizard, Gen Korean BBQ, and much much more.

Tapani Otala is the VP of Engineering at Tidepool, an open source, not-for-profit company focused on liberating data from diabetes devices, supporting researchers, and providing great, free software to people with diabetes and their care teams. He joins us today to share details of the Tidepool solution, how it enables enhanced visibility into Diabetes data and enables people living with this disease to better manage their condition.  Visit https://tidepool.org for more information.   Did you know that MongoDB is helping developers to fight Covid-19? We're offering Atlas credits for developers working on projects battling the pandemic. For more than a year, the world has been living and struggling with COVID-19. Vaccines are now being rolled out in many countries, but the global situation is still critical. In fact, many regions are battling through the most severe phase of the pandemic. Throughout it all, technologists have been coming together to develop applications to help detect, understand, and stop the spread of COVID-19. We are incredibly grateful to everyone who is working hard to tackle the virus, and this program is our small way of helping out. If you are working on a project to help combat COVID-19, apply on our web site and give us a bit of detail. Qualified applications intended to help fight this COVID-19 battle will receive $300 of MongoDB Atlas credits.    

Glucose Advisors sits down with Howard Look to talk about movies, FDA lockdown, crystal balls and importantly the future of diabetes management through the soon to be approved Tidepool Closed Loop app! Joining the podcast is Christopher Snider, Tidepool's Community and Clinical success manager. Full show notes Community discussions Programs Courses

Today I'd like to introduce you to Ben West. Ben was diagnosed with Diabetes Type 1, at 21 years of age, and if you or any of your friends or loved ones have a similar diagnosis, you are definitely going to learn so much from Ben.Ben is currently a Staff Product Engineer at Dexcom, a global leader in diabetes care transformation and management, where they design, and manufacture continuous glucose monitoring devices (CGM), and you'll hear a lot more about that technology in today's talk. He spends his time today at Dexcom helping to prioritize where investments in innovation are spent, and which ideas to accelerate into the concept funnel that will yield the most impact for the organization and its customers.Ben spent the last 5 years, as part of his personal mission to reduce the burden of living with Diabetes Type 1, reverse engineering the open loop system of the insulin pump and has done a tremendous amount of work there, and is also a co-founder of the NightScout Project, an open source cloud based system that provides the availability of CGM information to web browsers, smartphones, and other devices, to help people with the diseases, manage the condition in real time and even predictively based on their bio metrics, activity, and glucose levels. Ben has also spent some time doing engineering work with Tidepool.org, which is a software that is helping to take the DIY capability of addressing both the data on the insulin pump and the data on the CGM, merging this data into a closed loop system, and providing prescriptive suggestions on ongoing therapy. Currently the software is up for approval with the FDA, and is looking to be democratized and provided within app stores for easy consumption. Ben also spent some time as a Cloud Networking Engineer at Cisco, and you'll see some of his experience in these capacities play out in the talk. Ben has a wealth of experience in software engineering and networking all up, and is a very reliable resource to follow and listen to as he discusses some big themes around the value of high fidelity solutions in healthcare.Some key topics we cover in the talk:-the journey, the community, and the people that have been working really hard on effectively creating high fidelity therapies to treat Diabetes Type 1-The definition of creating some high fidelity technology: the ratio of effort and the output of some external good from that effort-approaching the development of new tech, and some basic philosophies around capitalistic vs open cultures of development and innovation as they pertain to solving important problemsThank you for listening!How to contact Ben:Twitter: @bewestisdoingbewest@gmail.comGithub: bewestPeople mentioned:https://twitter.com/danamlewishttps://twitter.com/loudnatehttps://twitter.com/scottleibrandhttps://twitter.com/danamlewishttps://twitter.com/AliMazaheriHelpful resources and items mentioned:https://www.dexcom.com/https://peterattiamd.com/kevinsayer/https://openaps.org/https://loopkit.github.io/loopdocs/https://www.tidepool.org/http://nightscout.github.io/https://www.tidepool.org/blog/tidepool-loop-medtronic-collaborationhttps://professional.diabetes.org/?loc=bb-dorghttps://www.linkedin.com/pulse/how-ai-redefining-manufacturing-wendy-curcuri-bauer/

Ali Mazaheri joins us on today's episode. Ali is currently the Chief Architect at the Microsoft Technology Center in Irvine, California, specializing in application development and open source software. He's spent the last 14 years at Microsoft in various customer facing technical roles, and spent his early career developing software in various industries including financial services and banking. Ali has been writing code since the age of 19, and as you'll see, his love and passion for technology bleeds through both technically and philosophically through the talk. Ali is also a thought leader and technical contributor in bio medical industry and community, through his work with continuous glucose monitoring solutions, and we talk about the organizations and solutions that he helps to contribute to and represent, including NightScout, Tidepool, and Loop.Ali, in every bit of his ethos, represents the current landscape of communal open source culture, where opportunities for interoperability, sharing vulnerabilities, learning from others, and contributing strengths in a pay it forward model, is helping him make meaningful impacts across to his customers, his community, and as you will hear, his family.Big themes covered in the talk:-A personal journey of Ali's family experiences, through his son Sam, with Diabetes Type 1, a genetic auto-immune disease: the hard human moments, and the communal evolution of open source technology-How the ethos of interoperability, sharing vulnerabilities, learning from others, and contributing strengths in a pay it forward model, has helped to make meaningful impacts across to customers, community, and family.-The real challenges of epidemics and disease to families, and why waiting cannot be an option.-How to teach big businesses to be more communal: sharing data, processes, innovations, and breakthroughs to empower each other for accelerations in human health and progress.-Re-coding your mindset to turn "being bitter", into "being better", the power of positivity and mental resiliency in the wake of life's challenges.Thank you so much for listening!Ways to Contact Ali:Twitter: https://twitter.com/AliMazaheriLinkedIn: https://www.linkedin.com/in/alimazaheri/People mentioned:https://twitter.com/shanselmanhttps://twitter.com/bewestisdoinghttps://twitter.com/danamlewishttps://www.linkedin.com/in/edraskin Resources:https://vimeo.com/user64743589/openapshttps://youtu.be/kv2S2f_C37Ahttps://openaps.org/https://loopkit.github.io/loopdocs/https://www.tidepool.org/https://www.microsoft.com/en-us/mtchttps://techcommunity.microsoft.com/t5/Student-Developer-Blog/Meet-the-2019-Imagine-Cup-World-Champion-team-EasyGlucose-from/ba-p/533238What is Open Source explained in LEGOLearn more at www.thedatabinge.comConnect with Derek on LinkedIn | Instagram | Twitter

Down the hill they go to the rocky tide pools. They see and touch sea animals. They even see a baby octopus!